The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
Cofer
B R
BR
Department of Surgery, University of Cincinnati College of Medicine, Shriner's Burns Institute, Ohio 45267-0558.
Davies
C B
CB
Alexander
J W
JW
Tchervenkov
J I
JI
D000284:Administration, Oral; D000527:Alprostadil / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D001803:Blood Transfusion; D016572:Cyclosporine / Q000494:pharmacology*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D016595:Misoprostol; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000276:immunology*
D007166:Immunosuppressive Agents; D016595:Misoprostol; D016572:Cyclosporine; D000527:Alprostadil; C054594:enisoprost